Dexmedetomidine (Precedex®) is an alpha-2 adrenergic agonist that can produce sedation and analgesia without causing respiratory depression. Its use has been described in patients undergoing mechanical ventilation, sedation for surgical and nonsurgical procedures, and prevention of withdrawal. We describe its use as an adjuvant analgesic in a patient with cancer pain refractory to multiple treatment modalities.
Get full access to this article
View all access options for this article.
References
1.
GerlachAT, MurphyCV, DastaJF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother, 2009; 43:2064–2074.
2.
HaselmanMA. Dexmedetomidine: A useful adjunct to consider in some high-risk situations. AANA J, 2008; 76:335–339.
3.
GerlachAT, DastaJF. Dexmedetomidine: An updated review. Ann Pharmacother, 2007; 41:245–252.
4.
Jackson KCKCIII, WohltP, FinePG. Dexmedetomidine: A novel analgesic with palliative medicine potential. J Pain Palliat Care Pharmacother, 2006; 20:23–27.
5.
PandharipandePP, PunBT, HerrDL, MazeM, GirardTD, MillerRR, ShintaniAK, ThompsonJL, JacksonJC, DeppenSA, StilesRA, DittusRS, BernardGR, ElyEW. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA, 2007; 298:2644–2653.
6.
RikerRR, ShehabiY, BokeschPM, CerasoD, WisemandleW, KouraF, WhittenP, MargolisBD, ByrneDW, ElyEW, RochaMG. SEDCOM (Safety, Efficacy of Dexmedetomidine Compared with Midazolam) Study Group. Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA, 2009; 301:489–499.
7.
MullerS, BorowicsSM, FortisEA, StefaniLC, SoaresG, MaguilnikI, BreyerHP, HidalgoMP, CaumoW. Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP. Gastrointest Endosc, 2008; 67:651–659.
8.
BekkerA, SturaitisM, BloomM, MoricM, GolfinosJ, ParkerE, BabuR, PittiA. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg, 2008; 107:1340–1347.
9.
BaddigamK, RussoP, RussoJ, TobiasJD. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med, 2005; 20:118–123.
10.
SadhasivamS, BoatA, MahmoudM. Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children. J Clin Anesth, 2009; 21:493–501.
11.
WallaceS, MecklenburgB, HanlingS. Profound reduction in sedation and analgesic requirements using extended dexmedetomidine infusions in a patient with an open abdomen. Mil Med, 2009; 174:1228–1230.
12.
BarlettaJF, MiedemaSL, WisemanD, HeiserJC, McAllenKJ. Impact of dexmedetomidine on analgesic requirements in patients after cardiac surgery in a fast-track recovery room setting. Pharmacotherapy, 2009; 29:1427–1432.
13.
ZhangX, SchmidtU, WainJC, BigatelloL. Bradycardia leading to asystole during dexmedetomidine infusion in an 18-year-old double-lung transplant recipient. J.Clin Anesth, 2010; 22:45–49.
14.
GerlachAT, MurphyCV. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: Case report and review of the literature. Pharmacotherapy, 2009; 29:1492.
15.
SoaresLG, NaylorC, MartinsMA, PeixotoG. Dexmedetomidine: A new option for intractable distress in the dying. J Pain Symptom Manage, 2002; 24:6–8.
